狂犬病减毒疫苗株口服免疫机理研究

基本信息
批准号:39900108
项目类别:青年科学基金项目
资助金额:14.00
负责人:张茂林
学科分类:
依托单位:中国人民解放军军需大学
批准年份:1999
结题年份:2002
起止时间:2000-01-01 - 2002-12-31
项目状态: 已结题
项目参与者:张茂林,邹啸环,姜力,于洪涛,雷连成,刘成华
关键词:
狂犬病免疫机理口服装
结项摘要

An attenuated rabies vaccine (SRV9 )and LT (heat-labile toxin derived from E coli) were inoculated mice by direct oral cavity instillation, stomach delivery and rectal instillation, respectively. The immune response and the role of LT were evaluated based on detection of specific lymphocyte proliferation in vitro, cytotoxin T cells response, titer of serum IgG and IgA, mucosal secretory (SIgA), neutralization index of serum antibody and protection rates after challenge, The results showed that the immune response evoked by rectal instillation were higher than others were. The immune responses in groups with LT were higher than without LT; Some biogradable materials such as gelatin, walnut oil and polybutylcyanoacrylate(PBCA) were chosen to encapsid the attenuated rabies vaccine, microspheres of different sizes were prepared and inoculated the mice by oral or i.m. inoculation. The data demonstrated that the encapsided microspheres can't stimulate protective immune response by either ways; Rabies virus and nucleoprotein gene were detected by histochemical stain under the electron microscope and by RT-PCR 6 hrs after oral delivery , neither antigen nor gene was detected in digestive tract; some material were tested for their delay characteristic in attenuated rabies vaccine, a stabilizer formula (including peptides, newborn cattle serum ,glycerol and EDTA )was found out, and a standard ELISA kit for detection the antibodies of dogs was also exploited.

. 将安全、免疫原性好的狂犬病病毒减毒疫苗株SRv9以口服途径免疫动物,ü芯恳呙绮《驹谙赖那秩氩课弧⒚庖呒し⒉课缓筒斡氲拿庖呋钚韵赴掷嗟任侍猓教挚袢〉目诜庖呋怼T诖嘶∩希芯坎煌陌痢⒚庖咴銮考炼蕴岣叨锟袢】诜庖哂Υ鹚降淖饔茫袢〉目诜呙绲难兄拼蛳禄。钪湛刂迫丝袢〉拇驹醋鞒龉毕住

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

钢筋混凝土带翼缘剪力墙破坏机理研究

钢筋混凝土带翼缘剪力墙破坏机理研究

DOI:10.15986/j.1006-7930.2017.06.014
发表时间:2017
2

结核性胸膜炎分子及生化免疫学诊断研究进展

结核性胸膜炎分子及生化免疫学诊断研究进展

DOI:10.3760/cma.j.issn.1674-2397.2020.05.013
发表时间:2020
3

抗生素在肿瘤发生发展及免疫治疗中的作用

抗生素在肿瘤发生发展及免疫治疗中的作用

DOI:10.3760/cma.j.cn371439-20200423-00009
发表时间:2021
4

硫化矿微生物浸矿机理及动力学模型研究进展

硫化矿微生物浸矿机理及动力学模型研究进展

DOI:
发表时间:2020
5

柔性基、柔性铰空间机器人基于状态观测的改进模糊免疫混合控制及抑振研究

柔性基、柔性铰空间机器人基于状态观测的改进模糊免疫混合控制及抑振研究

DOI:10.13465/j.cnki.jvs.2018.19.027
发表时间:2018

张茂林的其他基金

批准号:31072147
批准年份:2010
资助金额:35.00
项目类别:面上项目
批准号:11205073
批准年份:2012
资助金额:24.00
项目类别:青年科学基金项目
批准号:51762027
批准年份:2017
资助金额:38.00
项目类别:地区科学基金项目
批准号:61701369
批准年份:2017
资助金额:23.00
项目类别:青年科学基金项目
批准号:31272579
批准年份:2012
资助金额:84.00
项目类别:面上项目

相似国自然基金

1

伪狂犬病病毒变异株逃逸抗体介导的免疫保护的机制

批准号:31802163
批准年份:2018
负责人:周末
学科分类:C1804
资助金额:25.00
项目类别:青年科学基金项目
2

布氏菌减毒疫苗株M5-90的bp26蛋白表位分子修饰与初步免疫评价

批准号:31100657
批准年份:2011
负责人:王文敬
学科分类:C0804
资助金额:23.00
项目类别:青年科学基金项目
3

首例慢病毒疫苗-马传染性贫血减毒疫苗免疫机理的研究

批准号:30771994
批准年份:2007
负责人:周建华
学科分类:H1111
资助金额:28.00
项目类别:面上项目
4

先天性免疫分子在狂犬病病毒街毒株致病性中的作用研究

批准号:31101791
批准年份:2011
负责人:王化磊
学科分类:C1804
资助金额:21.00
项目类别:青年科学基金项目